Moleculin Biotech, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Moleculin Biotech, Inc. (MBRX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $5.03 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-18
- Moleculin Biotech, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $5.03M, a 20.49% decline from fiscal 2024.
- Moleculin Biotech, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $6.33M, a 4.28% decline from fiscal 2023.
- Moleculin Biotech, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $6.61M, a 3.80% decline from fiscal 2022.
- Moleculin Biotech, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $6.87M, a 38.68% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $5.03M 10-K · filed 2026-03-18 |
| 2024-12-31 | $6.33M 10-K · filed 2026-03-18 |
| 2023-12-31 | $6.61M 10-K · filed 2025-03-21 |
| 2022-12-31 | $6.87M 10-K · filed 2024-03-22 |
| 2021-12-31 | $4.96M 10-K · filed 2023-03-22 |
| 2020-12-31 | $4.45M 10-K · filed 2022-03-24 |
| 2019-12-31 | $3.56M 10-K · filed 2021-03-24 |
| 2018-12-31 | $3.29M 10-K · filed 2020-03-19 |
| 2017-12-31 | $1.16M 10-K · filed 2019-02-21 |
| 2016-12-31 | $1.24M 10-K · filed 2018-03-28 |
| 2015-12-31 | $155.00K 10-K · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |